Login
Cart
Support
Search
Search
Search
Home
eSymposia
ePanels
SciTalks
Virtual Recaps
Event Summary
Sessions
Engagement
More
Support
Preferred
(EDT)
Vaccines as Drugs for COVID‑19
9:00 AM - 11:35 AM EST
Thursday, January 14, 2021
Archive
Co-Chairs
Pierre Bruhns
Institut Pasteur
David Humphreys
UCB Pharma, UK
Other
Vaccines as Drugs for COVID‑19
The Challenges of a New Vaccine for a New Disease
9:00 AM - 9:15 AM EST
Thursday, January 14, 2021
Archive
Speaker
Liise-anne Pirofski
, MD
Albert Einstein College of Medicine and Montefiore Medical Center
Vaccines as Drugs for COVID‑19
Development of a Self‑Amplifying RNA Vaccine for COVID‑19
9:15 AM - 9:30 AM EST
Thursday, January 14, 2021
Archive
Speaker
Paul McKay
, PhD
Imperial College
Vaccines as Drugs for COVID‑19
Potent Vaccine Efficacy from mRNA‑1273 Expressing SARS‑CoV‑2 Spike Protein Stabilized in the Prefusion Conformation
9:30 AM - 9:45 AM EST
Thursday, January 14, 2021
Archive
Speaker
Andrea Carfi
, PhD
Moderna
Vaccines as Drugs for COVID‑19
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
9:45 AM - 10:00 AM EST
Thursday, January 14, 2021
Archive
Speaker
Alexander Muik
, PhD
BioNTech
Vaccines as Drugs for COVID‑19
Development of INO-4800, a DNA Vaccine for COVID-19
10:00 AM - 10:15 AM EST
Thursday, January 14, 2021
Archive
Speaker
Trevor Smith
Inovio
Vaccines as Drugs for COVID‑19
Development of ChAdOx1 nCoV‑19 (AZD1222); Creating a Vaccine in a Pandemic Setting
10:15 AM - 10:30 AM EST
Thursday, January 14, 2021
Archive
Speaker
Sarah Gilbert
, PhD
University of Oxford
Vaccines as Drugs for COVID‑19
Coffee Break
10:30 AM - 10:45 AM EST
Thursday, January 14, 2021
Vaccines as Drugs for COVID‑19
Janssen’s Efforts in the Development of an Ad26 Based COVID‑19 Vaccine
10:45 AM - 11:00 AM EST
Thursday, January 14, 2021
Archive
Speaker
Hanneke Schuitemaker
, PhD
Janssen Vaccines & Prevention B.V.
Vaccines as Drugs for COVID‑19
Development of the mRNA based SARS-CoV-2 Vaccine CVnCoV
11:00 AM - 11:15 AM EST
Thursday, January 14, 2021
Archive
Speaker
Susanne Rauch
CureVac GmbH
Vaccines as Drugs for COVID‑19
Intranasal Vaccination with ChAdOx1 nCoV 19 Results in Reduced Nasal Shedding and Lack of Lower Respiratory Tract Infection in SARS CoV 2 Hamsters and Rhesus Macaques
11:15 AM - 11:30 AM EST
Thursday, January 14, 2021
Archive
Speaker
Neeltje van Doremalen
, PhD
NIAID, National Institutes of Health
Vaccines as Drugs for COVID‑19
Closing Remarks
11:30 AM - 11:35 AM EST
Thursday, January 14, 2021
Archive
Vaccines as Drugs for COVID‑19
×
Evaluation
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by
clicking here
.
Close this Window